臨床試験

ENCIRCLE試験

NCT: NCT04153292 · ACTIVE_NOT_RECRUITING

NCT識別子NCT04153292

ステータスACTIVE_NOT_RECRUITING

開始日2020-11-12

完了2031-10-10

SponsorEdwards Lifesciences (INDUSTRY)

First posted2019-11-06

Last updated2026-10-06

概要

This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。